Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3) 3
adult (2) 2
aged (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
cancer (2) 2
chemotherapy (2) 2
clinical neurology (2) 2
disease progression (2) 2
female (2) 2
humans (2) 2
male (2) 2
middle aged (2) 2
oncology (2) 2
prognosis (2) 2
prospective studies (2) 2
surgery (2) 2
survival analysis (2) 2
treatment outcome (2) 2
adjuvant chemotherapy (1) 1
adjuvant temozolomide (1) 1
adolescent (1) 1
adults (1) 1
antineoplastic agents - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
astrocytoma (1) 1
benign brain neoplasm (1) 1
benign brain neoplasms (1) 1
benign neoplasm, brain (1) 1
benign neoplasms, brain (1) 1
biomarkers, tumor - analysis (1) 1
brain (1) 1
brain - pathology (1) 1
brain -- cancer -- periodicals (1) 1
brain -- cancer. 2fast (1) 1
brain -- periodicals (1) 1
brain -- tumors -- periodicals (1) 1
brain -- tumors. 2fast (1) 1
brain benign neoplasm (1) 1
brain benign neoplasms (1) 1
brain cancer (1) 1
brain cancers (1) 1
brain malignant neoplasm (1) 1
brain malignant neoplasms (1) 1
brain neoplasm (1) 1
brain neoplasm, benign (1) 1
brain neoplasm, malignant (1) 1
brain neoplasm, primary (1) 1
brain neoplasms (1) 1
brain neoplasms - drug therapy (1) 1
brain neoplasms - radiotherapy (1) 1
brain neoplasms -- periodicals (1) 1
brain neoplasms periodicals (1) 1
brain neoplasms, benign (1) 1
brain neoplasms, malignant (1) 1
brain neoplasms, malignant, primary (1) 1
brain neoplasms, primary (1) 1
brain neoplasms, primary malignant (1) 1
brain periodicals (1) 1
brain periodicals. cancer (1) 1
brain periodicals. tumors (1) 1
brain tumor (1) 1
brain tumor, primary (1) 1
brain tumor, recurrent (1) 1
brain tumors (1) 1
brain tumors, primary (1) 1
brain tumors, recurrent (1) 1
cancer of brain (1) 1
cancer of the brain (1) 1
cancer, brain (1) 1
cancers, brain (1) 1
carmustine wafers (1) 1
cerebro (1) 1
cerebrum (1) 1
clinical medicine (1) 1
combined modality therapy (1) 1
confidence intervals (1) 1
diagnostic techniques, neurological (1) 1
disease-free survival (1) 1
dna modification methylases - genetics (1) 1
dna repair enzymes - genetics (1) 1
efficacy (1) 1
elderly-patients (1) 1
electronic journal (1) 1
electronic journals (1) 1
electronic periodicals (1) 1
endpoint determination (1) 1
evidence-based analysis (1) 1
fast (1) 1
fst00837592 (1) 1
fst00837679 (1) 1
gliadel wafers (1) 1
glioblastoma (1) 1
glioblastoma - drug therapy (1) 1
glioblastoma - radiotherapy (1) 1
glioblastoma-multiforme (1) 1
glioma - drug therapy (1) 1
glioma - radiotherapy (1) 1
health sciences (1) 1
high-grade glioma (1) 1
idh2 mutations (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Neuro-oncology
and Japan Society for Neuro-OncologySociety for Neuro-Oncology
Neuro-oncology, ISSN 1522-8517, 1999
Brain | Tumors
Journal
Details down arrow
2. Full Text NOA‐05 phase 2 trial of procarbazine and lomustine therapy in gliomatosis cerebri
by Glas, Martin and Bähr, Oliver and Felsberg, Jörg and Rasch, Katja and Wiewrodt, Dorothee and Schabet, Martin and Simon, Matthias and Urbach, Horst and Steinbach, Joachim P and Rieger, Johannes and Fimmers, Rolf and Bamberg, Michael and Nägele, Thomas and Reifenberger, Guido and Weller, Michael and Herrlinger MD, Ulrich and Group of the German Cancer Society, for the Neuro‐Oncology and German Canc Soc and Neuro-Oncology Group of the German Cancer Society
Annals of Neurology, ISSN 0364-5134, 09/2011, Volume 70, Issue 3, pp. 445 - 453
Objective: The NOA-05 multicenter trial was performed to analyze the efficacy of primary chemotherapy with procarbazine and lomustine (PC) in patients with... 
INITIAL TREATMENT | IDH2 MUTATIONS | RADIOTHERAPY | NEUROSCIENCES | CHEMOTHERAPY | CLINICAL NEUROLOGY | Procarbazine - administration & dosage | Prognosis | Prospective Studies | Humans | Middle Aged | DNA Repair Enzymes - genetics | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Antineoplastic Agents - therapeutic use | Neoplasms, Neuroepithelial - pathology | Karnofsky Performance Status | Tumor Suppressor Proteins - genetics | Endpoint Determination | Adult | Female | Neoplasms, Neuroepithelial - drug therapy | Biomarkers, Tumor - analysis | Treatment Outcome | Combined Modality Therapy | Disease Progression | Neoplasms, Neuroepithelial - surgery | Disease-Free Survival | Magnetic Resonance Imaging | DNA Modification Methylases - genetics | Sample Size | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Brain - pathology | Aged | Lomustine - administration & dosage | Confidence intervals | Multivariate analysis | Medical treatment | Medical prognosis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Neuro-Oncology Working Group 01 Trial of Nimustine Plus Teniposide Versus Nimustine Plus Cytarabine Chemotherapy in Addition to Involved-Field Radiotherapy in the First-Line Treatment of Malignant Glioma
by The Neuro-Oncology Working Group of the German Cancer Society and Neuro-Oncology Working Grp German Canc and Neuro-Oncology Working Group of the German Cancer Society and The Neuro-Oncology Working Group of the German Cancer Society
Journal of Clinical Oncology, ISSN 0732-183X, 09/2003, Volume 21, Issue 17, pp. 3276 - 3284
Purpose : The role of chemotherapy in the primary treatment of malignant glioma remains controversial. The results from the German-Austrian Glioma trial (GAG,... 
ADJUVANT CHEMOTHERAPY | PROGNOSTIC FACTORS | ASTROCYTOMA | SURGERY | METAANALYSIS | ONCOLOGY | RECURSIVE PARTITIONING ANALYSIS | GLIOBLASTOMA-MULTIFORME | ADULTS | RADIATION-THERAPY | TEMOZOLOMIDE | Nimustine - administration & dosage | Prognosis | Prospective Studies | Humans | Middle Aged | Male | Treatment Outcome | Teniposide - administration & dosage | Brain Neoplasms - drug therapy | Glioblastoma - radiotherapy | Glioma - radiotherapy | Disease Progression | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Survival Analysis | Adult | Female | Aged | Brain Neoplasms - radiotherapy | Glioblastoma - drug therapy | Glioma - drug therapy | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Carmustine wafer implantation for high-grade gliomas: Evidence-based safety efficacy and practical recommendations from the Neuro-oncology Club of the French Society of Neurosurgery
by Roux, A and Caire, F and Guyotat, J and Menei, P and Metellus, P and Pallud, J and Neuro-Oncology Club French Neur
Neurochirurgie, ISSN 0028-3770, 12/2017, Volume 63, Issue 6, pp. 433 - 443
There is a growing body of evidence that carmustine wafer implantation during surgery is an effective therapeutic adjunct to the standard combined... 
Chemotherapy | Glioblastoma | Efficacy | High-grade glioma | Safety | Carmustine wafers | Evidence-based analysis | SURGERY | NEWLY-DIAGNOSED GLIOBLASTOMA | MGMT PROMOTER METHYLATION | SURVIVAL CLINICAL ARTICLE | CLINICAL NEUROLOGY | ADJUVANT TEMOZOLOMIDE | PHASE-II TRIAL | RECURRENT MALIGNANT GLIOMA | TERM-FOLLOW-UP | RADIOTHERAPY PLUS CONCOMITANT | ELDERLY-PATIENTS | GLIADEL WAFERS | Life Sciences | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.